[go: up one dir, main page]

MX2022016174A - Composiciones y metodos para tratar un trastorno obsesivo-compulsivo. - Google Patents

Composiciones y metodos para tratar un trastorno obsesivo-compulsivo.

Info

Publication number
MX2022016174A
MX2022016174A MX2022016174A MX2022016174A MX2022016174A MX 2022016174 A MX2022016174 A MX 2022016174A MX 2022016174 A MX2022016174 A MX 2022016174A MX 2022016174 A MX2022016174 A MX 2022016174A MX 2022016174 A MX2022016174 A MX 2022016174A
Authority
MX
Mexico
Prior art keywords
compulsive disorder
compositions
methods
treating obsessive
obsessive
Prior art date
Application number
MX2022016174A
Other languages
English (en)
Inventor
Vladimir Coric
Robert Berman
Loren Aguiar
Original Assignee
Biohaven Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohaven Therapeutics Ltd filed Critical Biohaven Therapeutics Ltd
Publication of MX2022016174A publication Critical patent/MX2022016174A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se divulga en la presente un método para tratar el trastorno obsesivo-compulsivo en un paciente que lo necesite al administrar al paciente una forma de dosis que incluye una cantidad eficaz de troriluzol.
MX2022016174A 2020-06-24 2021-06-24 Composiciones y metodos para tratar un trastorno obsesivo-compulsivo. MX2022016174A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063043681P 2020-06-24 2020-06-24
PCT/US2021/038789 WO2021262914A1 (en) 2020-06-24 2021-06-24 Compositions and methods for treating obsessive-compulsive disorder

Publications (1)

Publication Number Publication Date
MX2022016174A true MX2022016174A (es) 2023-01-24

Family

ID=79281806

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022016174A MX2022016174A (es) 2020-06-24 2021-06-24 Composiciones y metodos para tratar un trastorno obsesivo-compulsivo.

Country Status (12)

Country Link
US (1) US20230181541A1 (es)
EP (1) EP4171554A4 (es)
JP (1) JP2023531919A (es)
KR (1) KR20230027189A (es)
CN (1) CN115968312A (es)
AU (1) AU2021297249A1 (es)
BR (1) BR112022025901A2 (es)
CA (1) CA3187323A1 (es)
IL (1) IL299301A (es)
MX (1) MX2022016174A (es)
PH (1) PH12022553441A1 (es)
WO (1) WO2021262914A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2982372T3 (pl) * 2005-04-05 2020-12-28 Yale University Środki modulujące stężenie glutaminianu stosowane w leczeniu zaburzeń psychicznych
SG10201908354VA (en) * 2015-03-03 2019-10-30 Biohaven Pharm Holding Co Ltd Riluzole prodrugs and their use
PT3297619T (pt) * 2015-05-22 2022-08-05 Vistagen Therapeutics Inc Utilizações terapêuticas de l-4-cloroquinurenina
AU2019223014B2 (en) * 2018-02-21 2024-10-17 Orphai Therapeutics Inc. Combination therapy with apilimod and glutamatergic agents
CN112203692A (zh) * 2018-05-27 2021-01-08 拜尔哈文制药股份有限公司 利鲁唑口腔崩解片用于治疗疾病的用途
KR20210034621A (ko) * 2018-07-22 2021-03-30 바이오하벤 테라퓨틱스 리미티드 알츠하이머병 치료를 위한 릴루졸 전구약물의 용도
AU2019322889A1 (en) * 2018-08-16 2021-03-04 Biohaven Therapeutics Ltd. Use of riluzole oral disintigrating tablets for treating diseases

Also Published As

Publication number Publication date
EP4171554A4 (en) 2024-07-31
JP2023531919A (ja) 2023-07-26
AU2021297249A1 (en) 2023-02-23
IL299301A (en) 2023-02-01
PH12022553441A1 (en) 2024-03-04
WO2021262914A1 (en) 2021-12-30
BR112022025901A2 (pt) 2023-01-10
CA3187323A1 (en) 2021-12-30
CN115968312A (zh) 2023-04-14
KR20230027189A (ko) 2023-02-27
US20230181541A1 (en) 2023-06-15
EP4171554A1 (en) 2023-05-03

Similar Documents

Publication Publication Date Title
EP4233861A3 (en) Compositions for treatment of essential tremor
ZA202109010B (en) Compounds and methods for the treatment of covid-19
JOP20200031A1 (ar) طرق لعلاج الالتهاب العظمي المفصلي باستخدام هلام من كانابيديول عبر الأدمة
MX2011007854A (es) Metodos para tratar infartos agudos al miocardio y trastornos relacionados.
NZ630367A (en) Methods of treatment of pediatric solid tumor
MX2024014121A (es) Metodos y composiciones para el tratamiento del exceso de glucocorticoides
MX2021004138A (es) Metodos y formulaciones para tratar nauseas y vomito inducidos por quimioterapias.
MX2021007330A (es) Composiciones y métodos terapéuticos para tratar cáncer usando ácido 6, 8-bis-benciltio-octanoico y un inhibidor de autofagia.
MX2020007817A (es) Prevención y tratamiento del trastorno del sueño.
MX2020007222A (es) Metodos para el tratamiento de afecciones inflamatorias de la piel.
PH12022553441A1 (en) Compositions and methods for treating obsessive-compulsive disorder
MX2023004516A (es) Uso de pridopidina y analogos para el tratamiento de la ansiedad y la depresion.
MX2023001233A (es) Metodos de tratamiento del cancer positivo para her2 con tucatinib en combinacion con trastuzumab, un taxano y un antagonista del vegfr-2.
EA202290027A1 (ru) Способы и композиции для улучшения результатов лечения пациентов с раком
MX2022005448A (es) Método de tratamiento de queratodermia palmoplantar.
EP4467131A3 (en) Microbiota restoration therapy (mrt) compositions and methods of manufacture
MX2023006704A (es) Composiciones dsg2 y metodos para el tratamiento de covid-19.
MX2023003723A (es) Anticuerpos anti-il-36r para el tratamiento de dolor inflamatorio cronico.
MX2023005031A (es) Compuesto degradante en un medicamento.
MX2023000151A (es) Terapia de combinacion de verapamilo y mometasona para el tratamiento de rinosinusitis cronica.
EP4491231A3 (en) Regimen for treating a neisseria gonorrhoeae infection with gepotidacin
ZA202202673B (en) Methods and compositions for treating endometriosis
MX2024002602A (es) Métodos para prevenir y tratar el dolor y síntomas asociados.
ATE501724T1 (de) Lektinzusammensetzung zur prophylaxe und/oder behandlung von unerwünschten arzneimittelnebenwirkungen
ZA202401786B (en) Compositions and methods for treating post-covid conditions of fatigue